Gastric MALT lymphoma in a patient receiving infliximab for psoriasis

British Journal of Dermatology

Volumn 159, Issue 2, 2008, Pages 497-498

  Girard, C ^a   Guillot, B ^a   Bessis, D ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

Gastric MALT lymphoma; Infliximab; Psoriasis

Indexed keywords

AMOXICILLIN; CD20 ANTIGEN; CLARITHROMYCIN; ESOMEPRAZOLE; INFLIXIMAB; METHOTREXATE;

ADULT; CANCER INVASION; CASE REPORT; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPHAGIA; ERADICATION THERAPY; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; LYMPHOMA CELL; MALE; MINIMAL RESIDUAL DISEASE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PSORIASIS; STOMACH BIOPSY; STOMACH LYMPHOMA; STOMACH ULCER; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; PSORIASIS; STOMACH NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47549104454     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08664.x     Document Type: Letter

References (11)

1. Brown SL, Greene MH, Gershon SK et al. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 2002 46 : 3151 8.
2. Geborek P, Bladstrom A, Turesson C et al. Tumor necrosis factor blockers do not increase overall tumor risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 2005 64 : 699 703.
3. Bongartz T, Sutton AJ, Sweeting MJ et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006 295 : 2275 85.
4. Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum 2007 56 : 1433 9.
5. Georgescu L, Quinn GC, Schwartzman S et al. Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment. Semin Arthritis Rheum 1997 26 : 794 804.
6. Frentz G, Olsen JH. Malignant tumours and psoriasis: a follow-up study. Br J Dermatol 1999 140 : 237 42.
7. Cliff S, Pettengell R, Gharge S, Marsden RA. B-cell lymphoma developing in a patient on cyclosporin for recalcitrant psoriasis. Br J Dermatol 1999 140 : 763 5.
8. Mahé E, Descamps V, Grossin M et al. CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab. Br J Dermatol 2003 149 : 170 3.
9. Nair B, Raval G, Mehta P. TNF-alpha inhibitor etanercept and hematologic malignancies: report of a case and review of the literature. Am J Hematol 2007 82 : 1022 4.
10. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993 342 : 575 7.
11. Thonhofer R, Gaugg M, Kriessmayr M et al. Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment. Ann Rheum Dis 2005 64 : 1098 9.